Introduction
When B lymphocytes are infected with the Epstein-Barr virus, the expression of EBI3 is induced. EBI3 encodes a secreted glycoprotein that belongs to the hematopoietin receptor family. It forms iIL-27 by heterodimerizing with a 28 kDa protein. EBI3 drives rapid clonal expansion of naive cd4(+) t-cells and strongly synergizes with IL-12 to activate IFN-gamma production of naive cd4(+) t-cells. EBI3's biological effects are mediated through the cytokine receptor wsx-1/tccr.
Description
Recombinant human EBI3 is produced in E. coli. It is a single, non-glycosylated polypeptide chain containing amino acids 21-229 of EBI3 and a 4.5kDa amino-terminal hexahistidine tag. This results in a protein fragment with a molecular weight of 34kDa. EBI3 is purified using proprietary chromatographic techniques.
Physical Appearance
The product is a clear solution that has been sterilized by filtration.
Formulation
EBI3 protein is supplied in a solution of 1xPBS and 50% glycerol.
Stability
If the entire vial will be used within 2-4 weeks, the product can be stored at 4°C. For longer storage periods, the product should be stored frozen at -20°C. Repeated freezing and thawing should be avoided.
Purity
Purity is determined by SDS-PAGE to be greater than 95.0%.
Synonyms
Interleukin-27 subunit beta, IL-27 subunit beta, IL-27B, Epstein-Barr virus-induced gene 3 protein, EBV-induced gene 3 protein, EBI3, IL27B.